Medicines and Related Substances Act, 1965
R 385
Directive and interpretations for completion of the quarterly return concerning credit risk (Form BA 210) |
Subregulation (4) Matters relating to valuation of security/collateral
Subregulation (6) Matters related to concentration risk, primarily credit concentration risk
Subregulation (7) Prescribed percentages and amounts relating to specified concentration risk
Subregulation (8) Matters related to exempt exposure
Subregulation (9) Matters specifically related to connected lending or lending to a related person
